Health

The world’s first DNA vaccine was approved for use in India recently. Developed by the Ahmedabad-based Zydus Cadila, ZyCoV-D is, as the name indicates, is a vaccine against Covid-19. Now, some researchers believe the technology — considered superior because DNA vaccines are easier to make and store, and, most importantly store an enormous amount of information — can be used to develop a vaccine for another tropical disease, dengue, a viral infection transmitted by mosquitoes.

The ministry of health and family welfare on Sunday said 53.5 per cent of people in the 18-44 age group have been inoculat

Researchers from the Council of Scientific and Industrial Research (CSIR)’s Pune-based National Chemical Laboratory (CSIR-NCL), Reliance Industries Ltd (RIL), and several other companies from Pune have pooled their expertise to manufacture moulded plastic components from COVID-19 PPE waste.

The new study conducted by researchers at the Indian Institutes of Science Education and Research (IISER) – Mohali, has now filled the gap. It has shown that a local signaling system defined by two genes called Ultrabithorax (Ubx) and Collier in the tertiary lobe regulated the activities of the progenitors in the tertiary as also secondary lobes and that the system shared several biomarkers with the local environment of the primary lobe.

HIV (Human Immunodeficiency Virus) is a virus that attacks the body’s immune system. HIV causes AIDS (Acquired Immune Deficiency Syndrome) and interferes with the body’s ability to fight infections. About HIV AIDS, it is believed that treatment can provide relief, but this condition cannot be cured. The treatment for HIV is called antiretroviral therapy (ART). ART involves taking a combination of HIV medicines (called an HIV treatment regimen) every day.

In the financial year 2020-21, India Inc. spent over Rs 1,600 crore (US$ 217.02 million) battling the second wave of Covid-19, according to a report released on Monday. According to a research done by CSR information and impact analytics platform ‘CSRBOX’ on over 350 publicly traded businesses, Indian corporations implemented over 750 corporate social responsibility projects in response to the second wave.

Co-WIN has developed a new API called ‘Know Your Customer’s/Client’s Vaccination Status’ or KYC-VS. To use this API, an individual needs to enter his/her mobile number and name. Thereafter, they will get an OTP which they have to enter. In return, Co-WIN will send a response to the verifying entity on the individual’s status of vaccination

Anti-Covid jabs available in India are around 97% effective in preventing mortality, whereas vaccination also significantly reduces hospitalisation, the assessment of real time vaccination data captured under Covid Vaccine tracker shows.